Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 06, 2020

SELL
$1.96 - $7.96 $66,836 - $271,436
-34,100 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$4.37 - $9.91 $23,598 - $53,514
5,400 Added 18.82%
34,100 $147,000
Q2 2019

Aug 14, 2019

BUY
$8.77 - $12.49 $5,262 - $7,494
600 Added 2.14%
28,700 $277,000
Q1 2019

May 13, 2019

BUY
$10.45 - $13.94 $66,880 - $89,216
6,400 Added 29.49%
28,100 $321,000
Q4 2018

Feb 11, 2019

SELL
$10.43 - $17.39 $7,301 - $12,173
-700 Reduced 3.13%
21,700 $255,000
Q3 2018

Nov 14, 2018

BUY
$11.95 - $19.63 $267,680 - $439,712
22,400 New
22,400 $369,000

About Eloxx Pharmaceuticals, Inc.


  • Ticker ELOX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,656,200
  • Description
  • Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis p...
More about ELOX
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.